CECAD

Old drug, new target: Rapamycin changes the way our DNA is stored

09.06.2021 | TopNews Prof. Dr. Linda Partridge

The anti-aging compound rapamycin influences DNA winding. © Hanna Salmonowicz, Monney Medical Media, 2021

Researchers discover an unexpected link between DNA winding and metabolism in the gut to ameliorate aging

Our genetic material is stored in our cells in a specific way to make the meter-long DNA molecule fit into the tiny cell nucleus of each body cell. An international team of researchers at the Max Planck Institute for Biology of Aging, the CECAD Cluster of Excellence in Aging research at the University of Cologne, the University College London and the University of Michigan have now been able to show that rapamycin, a well-known anti-aging candidate, targets gut cells specifically to alter the way of DNA storage inside these cells, and thereby promotes gut health and longevity. This effect has been observed in flies and mice. The researchers believe this finding, which is published in the scientific journal eLife, will open up new possibilities for targeted therapeutic interventions against aging.

Our genetic material lies in the form of DNA in every cell nucleus of our body cells. In humans, this DNA molecule is two meters long – yet it fits into the cell nucleus, which is only a few micrometers in size. This is possible because the DNA is precisely stored. To do this, it is wound several times around certain proteins known as histones. How tightly the DNA is wound around the histones also determines which genes can be read from our genome. In many species, the number of histones changes with age. Until now, however, it is unclear whether changes in cellular histone levels could be utilized to improve the aging process in living organisms.

Rapamycin is a well-known anti-aging compound – with a new target

The drug rapamycin recently became one of the most promising anti-aging substances and shows positive effects on health in old age. “Rapamycin turns down the TOR signaling pathway that regulates a wide spectrum of basic cellular activities such as energy, nutritional and stress status. In short, we use rapamycin to fine-tune the master regulator of cellular metabolism”, explains Yu-Xuan Lu, postdoc in the department of Linda Partridge and first author of the study. “Meanwhile, we know that histone levels have a critical impact on the aging process. However, we had no idea whether there is a link between the TOR signaling pathway and histone levels, and more importantly, whether histone levels could be a druggable anti-aging target.”

To study the effect of rapamycin on histone proteins, the researchers analyzed various organs of the fruit fly Drosophila melanogaster. “We looked in different tissues and organs of the fly for noticeable changes in histone levels before and after treatment with rapamycin, this means before and after switching off the TOR signaling pathway”, explains Yu-Xuan Lu. “Surprisingly, we observed an increase in histone proteins after rapamycin treatment. This effect occurred exclusively in the gut of the flies, but not in other tissues.” In further experiments, Yu-Xuan Lu and his colleagues were able to show that the increased levels of certain histone proteins in a specific gut cell type called enterocytes reduced tumor growth, improved gut health and extended lifespan of the animals. Similar observations were made in mouse gut enterocytes after rapamycin treatment.

“Our results show for the first time a link between the TOR signaling pathway and histone levels that determines longevity”, says Yu-Xuan Lu. “The increased levels of histone proteins subsequently change how the DNA is stored in the nucleus. The fact that we were also able to make similar observations in mice shows that this is a widespread mechanism.” Looking ahead to future experiments, he adds: “Given the central role of histones on DNA storage in the cell, this finding not only broadens our knowledge on the aging process, but also provides new possibilities for targeted therapeutic interventions against aging.”

This project has received funding from the European Union’s Horizon 2020 research, the Glenn Foundation for Medical Research, and the Max-Planck-Gesellschaft. Yu-Xuan Lu was supported by an EMBO Long-Term Fellowship.


Original Publication:

Yu-Xuan Lu, Jennifer C. Regan, Jacqueline Eßer, Lisa F. Drews, Thomas Weinseis, Julia Stinn, Oliver Hahn, Richard A. Miller, Sebastian Grönke and Linda Partridge. A TORC1-histone axis regulates chromatin organisation and non-canonical induction of autophagy to ameliorate ageing. eLife, 2021 

Online: 14.05.2021, DOI: 10.7554/eLife.62233

URL: elifesciences.org/articles/62233


Further information can be found in the press release of the Max Planck Institute Ageing Research under the following link: 

https://www.age.mpg.de/communications/news/detail/old-drug-new-target-rapamycin-changes-the-way-our-dna-is-stored